Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2010
03/17/2010CN101669663A Mulberry active juice beverage for sobering up and protecting liver and preparation method thereof
03/17/2010CN101669635A Herbal cuisine for invigorating spleen and stomach and preparation method thereof
03/17/2010CN100594036C Animal medicine capable of rehabilitating intestinal tract injury
03/17/2010CN100594027C Percutaneous medicine of strychnine, toxiferine, securinine and salt thereof
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678884 Biologically active peptide and agent containing the same
03/16/2010US7678834 Substituted 4-aminocyclohexanol compounds
03/16/2010US7678816 Method of stabilizing lansoprazole
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010US7678810 activin receptor-like kinase 5 (ALK5) (which is a TGF- beta type I receptor) inhibitor ; glomerulonephritis, diabetic nephropathy, hepatic fibrosis, liver cirrhosis, pulmonary fibrosis, or alopeciarosis; hair growth stimulant
03/16/2010US7678805 inhibitors are unable to promote death of IL-3 dependent cells cultured in presence of IL-3; non-toxic, selective and potent
03/16/2010US7678796 MGluR5 modulators I
03/16/2010US7678786 Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol
03/16/2010US7678777 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times
03/16/2010US7678558 Method for overexpression of zwitterionic polysaccharides
03/16/2010US7678390 For therapy of heart, lung, liver, spleen, brain, skin and kidney diseases and other conditions and disease states including, for example, asthma, emphysema, bronchitis, adult respiratory distress syndrome, sepsis, cystic fibrosis
03/16/2010US7678370 Methods of preventing peritonitis by administering lactic acid bacterium
03/16/2010US7678369 Administering a polymer with pendant acid functional groups or a salt with a pharmaceutically acceptable cation; free of acid anhydride groups; antidiarrhea agents
03/16/2010CA2566691C Apparatus and method for delivery of therapeutic and/or diagnostic agents
03/16/2010CA2437718C Carboline derivatives
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2390590C Adenosine receptor antagonists and methods of making and using the same
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/16/2010CA2372575C Bradykinin receptor antagonists
03/16/2010CA2362772C Pharmaceutical formulation for intraveous or intramuscular octreotide administration
03/16/2010CA2200054C Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/11/2010WO2010027498A2 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes emillitus, pre-diabetic symptoms, insulin resistance and related disease states and conditions
03/11/2010WO2010027473A2 Immunogenic escherichia coli heat stable enterotoxin
03/11/2010WO2010027014A1 Method for improving absorption of s-adenosyl-l-methionine, and composition having improved s-adenosyl-l-methionine absorption
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010WO2010026966A1 Novel anti-hcv agent and use thereof
03/11/2010WO2010026701A1 Osteogenesis promoter comprising [4-(methylthio)phenylthio]methanebisphosphonic acid or pharmaceutically acceptable salt thereof as active ingredient
03/11/2010WO2010026487A1 Therapeutic methods and compositions
03/11/2010WO2010025856A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
03/11/2010WO2010025483A1 Treatment of fructose malabsorption
03/11/2010WO2009154810A3 Delivery systems for multiple active agents
03/11/2010WO2009142772A3 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
03/11/2010WO2009090453A3 Compositions comprising (r) -verapamil having mt1 receptor activity
03/11/2010US20100063158 Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
03/11/2010US20100063105 Pharmaceutical uses and synthesis of nicotinanilide-n-oxides
03/11/2010US20100063101 New benzimidazole derivatives
03/11/2010US20100063095 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063062 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
03/11/2010US20100063025 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of RHO-Kinase
03/11/2010US20100063018 orphan nuclear receptor modulators such as 23-N-Carbacinnamyloxy-3 alpha ,7 alpha -dihydroxy-5 beta -norcholanylamine, used for the treatment of liver, gastrointestinal, kidney, cardiovascular or metabolic disorders
03/11/2010US20100063010 Method for administering a spill resistant pharmaceutical system
03/11/2010US20100062988 Chewable sustained release formulations
03/11/2010US20100062090 Pharmaceutical Composition Comprising Metadoxine and Garlic Oil For Preventing and Treating Alcohol-Induced Fatty Liver and Steatohepatitis
03/11/2010US20100062084 Treatment Of Gastrointestinal Diseases
03/11/2010US20100062063 Light-stable solid pharmaceutical composition of ramosetron
03/11/2010US20100062059 S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such Compositions
03/11/2010US20100062024 Biologically Active Hemagglutinin From Type A Clostridium Botulinum and Methods of Use
03/11/2010US20100061999 Antihuman tnf-alpha antibody activity lowering inhibitor
03/11/2010US20100061944 Oral hygiene composition comprising myrtle
03/11/2010US20100061943 Oral health composition comprising alchemilla vulgaris
03/11/2010CA2735842A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
03/11/2010CA2735465A1 Treatment of fructose-malabsorption
03/11/2010CA2730328A1 Immunogenic escherichia coli heat stable enterotoxin
03/10/2010EP2161329A1 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
03/10/2010EP2161282A1 Peptide analogues of PACAP
03/10/2010EP2161280A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
03/10/2010EP2161262A1 THCV and THCV extracts derived from plant material
03/10/2010EP2161034A1 Treatment of fructose malabsorption
03/10/2010EP2160470A2 Chimeric pufa polyketide synthase systems and uses thereof
03/10/2010EP2160377A1 Targeting diazo prodrugs for the treatment of gastrointestinal diseases
03/10/2010EP2160190A1 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
03/10/2010EP1313699B1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
03/10/2010CN101664388A transnasal transport/immunisation with highly adaptable carriers
03/09/2010US7674938 Selective beta 3-adrenoceptor stimulants; obesity, diabetes mellitus, hyperlipidemia, pollakiuria, urinary incontinence, intestinal hypermotility; e.g. 4'-{2-[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl ethylamino]ethoxy}-2,3',5'-trimethylbiphenyl-4-carboxylic acid
03/09/2010US7674825 Cardiovascular disorders; stimulant of guanylate cyclase
03/09/2010US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
03/09/2010US7674777 Immunostimulatory nucleic acid molecules
03/09/2010US7674775 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants
03/09/2010US7674773 Glycosylated derivative of hypolipemic agents; side effect reduction; therapy for insulin resistance; hyperlipidemia agent; impaired lipid metabolism; lowering cholesterol levels
03/09/2010US7674613 Lactobacillus salivarius; gingivitis, periodontitis, periodontal disease, caries and halitosis
03/09/2010US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution
03/09/2010US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist
03/09/2010CA2428015C Process for the rehydration of magaldrate powder
03/09/2010CA2424346C Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
03/09/2010CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators
03/04/2010WO2010025267A2 Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
03/04/2010WO2010025135A2 Trimeprazine and ethopropazine derivatives for promoting bone growth
03/04/2010WO2010025126A1 Rapidly disintegrating tablets comprising lipase, amylase, and protease
03/04/2010WO2010024384A1 Anti-hepatitis c virus composition
03/04/2010WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity
03/04/2010WO2010024138A1 Glucosyltransferase inhibitor comprising epigallocatechin gallate polymer as active ingredient
03/04/2010WO2010023874A1 Film preparation containing loperamide hydrochloride
03/04/2010WO2010023742A1 Method of producing cariostatic composition
03/04/2010WO2010023422A1 Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation
03/04/2010WO2010023178A1 Pharmaceuticals comprising a bacterial polysaccharide
03/04/2010WO2009138198A3 Compositions comprising hydroxytyrosol for the preventive and curative treatment of intestinal tract disorders
03/04/2010US20100056632 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
03/04/2010US20100056577 Pyrrole compounds
03/04/2010US20100056531 Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
03/04/2010US20100056507 Phenyl derivatives and their use as a medicament
03/04/2010US20100056496 Muscarinic receptor antagonists
03/04/2010US20100056472 Grain compositions containing pre-biotic isomalto-oligosaccharides and methods of making and using same
03/04/2010US20100056459 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
03/04/2010US20100056432 Template-fixed peptidomimetics with antibacterial activity
1 ... 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 ... 1258